Literature DB >> 12444088

A viral RNA that binds ATP and contains a motif similar to an ATP-binding aptamer from SELEX.

Dan Shu1, Peixuan Guo.   

Abstract

The intriguing process of free energy conversion, ubiquitous in all living organisms, is manifested in ATP binding and hydrolysis. ATPase activity has long been recognized to be a capability limited to proteins. However, the presence of an astonishing variety of unknown RNA species in cells and the finding that RNA has catalytic activity have bred the notion that RNA might not be excluded from the group of ATPases. All DNA-packaging motors of double-stranded DNA phages involve two nonstructural components with certain characteristics typical of ATPases. In bacterial virus phi29, one of these two components is an RNA (pRNA). Here we report that this pRNA is able to bind ATP. A comparison between the chemically selected ATP-binding RNA aptamer and the central region of pRNA reveals similarity in sequence and structure. The replacement of the central region of pRNA with the sequence from ATP-binding RNA aptamer produced chimeric aptRNA that is able to both bind ATP and assemble infectious viruses in the presence of ATP. RNA mutation studies revealed that changing only one base essential for ATP binding caused both ATP binding and viral assembly to cease, suggesting that the ATP binding motif is the vital part of the pRNA that forms a hexamer to drive the phi29 DNA-packaging motor. This is the first demonstration of a natural RNA molecule that binds ATP and the first case to report the presence of a SELEX-derived RNA aptamer in living organisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444088     DOI: 10.1074/jbc.M209895200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Selection and evolution of NTP-specific aptamers.

Authors:  Laure Weill; Dominique Louis; Bruno Sargueil
Journal:  Nucleic Acids Res       Date:  2004-09-27       Impact factor: 16.971

2.  Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology.

Authors:  Dan Shu; Wulf-Dieter Moll; Zhaoxiang Deng; Chengde Mao; Peixuan Guo
Journal:  Nano Lett       Date:  2004-09       Impact factor: 11.189

Review 3.  RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.

Authors:  Peixuan Guo
Journal:  J Nanosci Nanotechnol       Date:  2005-12

4.  Modular assembly of chimeric phi29 packaging RNAs that support DNA packaging.

Authors:  Yun Fang; Dan Shu; Feng Xiao; Peixuan Guo; Peter Z Qin
Journal:  Biochem Biophys Res Commun       Date:  2008-06-02       Impact factor: 3.575

5.  Structure and assembly of the essential RNA ring component of a viral DNA packaging motor.

Authors:  Fang Ding; Changrui Lu; Wei Zhao; Kanagalaghatta R Rajashankar; Dwight L Anderson; Paul J Jardine; Shelley Grimes; Ailong Ke
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-06       Impact factor: 11.205

Review 6.  Clinical applications of nucleic acid aptamers in cancer.

Authors:  Xiaoyu Pei; Jun Zhang; Jie Liu
Journal:  Mol Clin Oncol       Date:  2014-02-10

Review 7.  RNA sensors: novel regulators of gene expression.

Authors:  Raymond Kaempfer
Journal:  EMBO Rep       Date:  2003-11       Impact factor: 8.807

Review 8.  Engineering RNA for targeted siRNA delivery and medical application.

Authors:  Peixuan Guo; Oana Coban; Nicholas M Snead; Joe Trebley; Steve Hoeprich; Songchuan Guo; Yi Shu
Journal:  Adv Drug Deliv Rev       Date:  2010-03-15       Impact factor: 15.470

Review 9.  Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy.

Authors:  Tae Jin Lee; Chad Schwartz; Peixuan Guo
Journal:  Ann Biomed Eng       Date:  2009-06-04       Impact factor: 3.934

10.  On the origin of life in the zinc world: 1. Photosynthesizing, porous edifices built of hydrothermally precipitated zinc sulfide as cradles of life on Earth.

Authors:  Armen Y Mulkidjanian
Journal:  Biol Direct       Date:  2009-08-24       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.